The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 73 (6) , 632-638
- https://doi.org/10.1111/j.1464-410x.1994.tb07547.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trialsControlled Clinical Trials, 1989
- The Effect of Intravesical Thiotepa on the Recurrence Rate of Newly Diagnosed Superficial Bladder Cancer. An MRC StudyBritish Journal of Urology, 1985
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- Intravesical Thiotepa Prophylaxis of Superficial Bladder CancerEuropean Urology, 1983
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Early Multiple‐dose Adjuvant Thiotepa in the Control of Multiple and Rapid TI Tumour NeogenesisBritish Journal of Urology, 1981
- The Use of Intravesical Thio-Tepa in the Management of Non-invasive Carcinoma of the BladderJournal of Urology, 1981
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976